Medication Adherence and Optimization

Medication adherence and optimization concerns the extent to which patients take medicines as intended, why they often do not, and how therapy can be supported and refined over time. Even a well-chosen, correctly dosed drug delivers its expected benefit only if the patient actually takes it as agreed, making adherence a central determinant of real-world treatment outcomes.

Definition

Medication adherence is the extent to which a person's medicine-taking corresponds to the agreed regimen; optimisation is the ongoing process of supporting adherence and refining therapy - in regimen, choice, and number of medicines - so that the intended benefit is realised with minimal burden and harm.

Scope

The topic covers the definition and measurement of adherence and persistence, the patient, regimen, and system factors that shape them, the interventions studied to support adherence, and the broader idea of optimising therapy - simplifying regimens, removing unnecessary drugs, and aligning treatment with patient goals. It is a reference topic and does not prescribe specific interventions for any patient.

Core questions

• What do adherence, persistence, and concordance mean, and how are they measured?
• Which patient, regimen, and system factors drive non-adherence?
• What interventions have been shown to improve adherence?
• How does optimising or simplifying a regimen affect adherence and outcomes?
• How does non-adherence affect the interpretation of treatment effect?

Key concepts

• Adherence, persistence, and concordance
• Intentional versus unintentional non-adherence
• Regimen complexity and pill burden
• Adherence measurement methods
• Patient-centred and shared decision-making
• Multicomponent adherence interventions
• Therapy optimisation and simplification

Mechanisms

Non-adherence arises from many interacting sources: patient beliefs and understanding, the complexity and burden of the regimen, side effects, cost, the asymptomatic nature of many treated conditions, and features of the health-care system. It may be unintentional, as when a dose is forgotten, or intentional, as when a patient decides not to take a drug. Because these drivers are diverse, single tactics rarely suffice; interventions that improve adherence tend to be multicomponent and tailored, combining education, reminders, regimen simplification, and follow-up. Optimisation extends this by revisiting the regimen itself - reducing complexity, deprescribing where appropriate, and aligning therapy with the patient's goals - so that what the patient is asked to do is both manageable and worthwhile.

Clinical relevance

Supporting adherence and optimising therapy are core functions of clinical pharmacy, because they determine whether sound drug choices translate into benefit. As a reference topic this entry explains the determinants of adherence and the evidence on supporting it; it describes how adherence is understood and is not a source of individualised counselling or treatment recommendations.

Epidemiology

Non-adherence to long-term therapy is common, with a large share of patients on chronic medicines deviating from the intended regimen; the problem is amplified in multimorbidity and polypharmacy, where many patients take several medicines for several conditions at once, increasing regimen complexity and burden.

Evidence & guidelines

Systematic reviews of adherence interventions for self-administered medicines in chronic disease find that some approaches improve adherence, but effects are variable and the most effective strategies tend to be multifaceted rather than single-component; this evidence frames how adherence support is designed.

History

Attention shifted over recent decades from a paternalistic notion of patient compliance toward concepts of adherence and concordance that emphasise the patient's active role and shared decision-making. Recognition that non-adherence is widespread and costly drove systematic study of its determinants and of interventions to support it.

Debates

How well can adherence be measured?

No single method captures medicine-taking perfectly: self-report, pharmacy refill records, electronic monitoring, and biological assays each have limitations, so estimates of adherence and of intervention effects depend on the measure used.

Seminal works

• osterberg-2005
• viswanathan-2012

Frequently asked questions

What is the difference between adherence and persistence?

Adherence describes how closely a patient follows the agreed regimen while taking a medicine; persistence describes how long they continue therapy before stopping. A patient can be persistent yet imperfectly adherent, or adherent for a time and then discontinue.

Why do single reminders often fail to fix non-adherence?

Non-adherence has many causes - beliefs, side effects, cost, complexity, forgetting - so a single tactic addresses only part of the problem; the most effective approaches tend to combine several tailored components.